Physician profile
Robert Mitchell
NPI 1669452975
$2,630.28
in general payments reported to CMS, 2019-2025
14 companies · $821 in 2025
The $821 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $832 · 2021: $380 · 2022: $187 · 2023: $179 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604 · Travel and Lodging: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.45 |
| Travel and Lodging | $395.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $897.97 | 2021-2025 | Avenir, Persona |
| Medinc of Texas | $746.00 | 2020 | |
| Depuy Synthes Sales INC. | $212.60 | 2019-2025 | Monovisc, Orthovisc |
| Sanara Medtech INC. | $162.41 | 2023 | Celleraterx |
| Stryker Corporation | $153.98 | 2019-2025 | Mako |
| Allergan, INC. | $100.03 | 2019 | |
| Next Science LLC | $86.05 | 2021 | |
| Kci USA, INC. | $84.29 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $51.27 | 2025 | |
| Heraeus Medical, LLC. | $37.44 | 2022 | |
| Smith+Nephew, INC. | $32.43 | 2019 | |
| Globus Medical, INC. | $29.63 | 2025 | Senza |
| Davol INC. | $20.50 | 2025 | Surgiphor |
| E.R. Squibb & Sons, L.L.C. | $15.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.